Log In
BCIQ
Print this Print this
 

Aurora + FLT3 inhibitor

  Manage Alerts
Collapse Summary General Information
Company Sareum Holdings plc
DescriptionInhibitor of aurora kinases and FMS-like tyrosine kinase 3 (FLT3; CD135)
Molecular Target Aurora kinases ; FMS-like tyrosine kinase 3 (FLT3) (CD135)
Mechanism of ActionFMS-like tyrosine kinase 3 (FLT3) inhibitor; Aurora kinase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationAcute myelogenous leukemia (AML)
Indication DetailsTreat acute myelogenous leukemia (AML)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
Get a free BioCentury trial today